(iii)

Regulation (EU) No 536/2014 of the European Parliament and of the Council of 16 April 2014 on clinical trials on medicinal products for human use, and repealing Directive 2001/20/EC Text with EEA relevance · European Union

the conditions under which the clinical trial is to be conducted, including the expected duration of the subject's participation in the clinical trial; and

← art_29__para_2__point_a__point_ii__text_1 · All articles · art_29__para_2__point_a__point_iii__text_1 →

Source: EUR-Lex (Cellar) · retrieved 2026-11-06 · Text as adopted (Official Journal); later amendments are not incorporated in this text.